EarlyCDT®-Lung cancer tests are performed in our CLIA compliant laboratory in Kansas, US

Our Kansas lab is also COLA certified for high quality of service to physicians, patients and lab partners

EarlyCDT®-Lung tests are also performed in professional laboratories around the world using our test kit. This kit is CE marked and meets the strict EU standards of manufacturing and quality control of the In Vitro Diagnostics Medical Devices Directive 98/79/EC

Oncimmune’s Quality Management System is certified to EN ISO 13485:2016 for the design, development and manufacture of in vitro diagnostic immune biomarker devices for early detection of solid tumour cancers (ISO Certificate).

Oncimmune is fully compliant with HIPAA and EU data protection regulations.

Oncimmune complies with all other relevant US and EU regulations.



Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept